乐普生物-B首次实现盈利 预计上半年利润不少于2400万元

格隆汇
Aug 06

格隆汇8月6日丨乐普生物-B(02157.HK)公布,截至2025年6月30日止六个月,预计公司将录得利润不少于人民币2,400万元,而截至2024年6月30日止六个月的上年同期则亏损约人民币1.97亿元。这是公司首次实现盈利。公司于报告期转亏为盈主要得益于收入的大幅成长,其中主要包括与ArriVent BioPharma, Inc.就MRG007开展的许可合作收入,以及普佑恒?(普特利单抗注射液...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10